CAMBRIDGE, Mass.--Aura Biosciences announced today that it will participate in the Boston Miles for Melanoma 5K Run/Walk, in support of the Melanoma Research Foundation’s (MRF) research, advocacy and education efforts. Aura has partnered with CURE OM, the Community United for Research and Education of Ocular Melanoma, to form a joint team for this event.
“Participating in this weekend’s Miles for Melanoma event here in Boston is a terrific opportunity for Aura to come together with the community to raise awareness for ocular melanoma and the Melanoma Research Foundation,” said Elisabet de los Pinos, CEO of Aura Biosciences. “We’re looking forward to walking alongside CURE OM’s co-founder and director, Sara Selig, and other fellow supporters of melanoma education and research.”
The Boston Miles for Melanoma Run/Walk will begin at 8:30 a.m. on July 9 in Brighton, Mass. This is the second-annual Miles for Melanoma 5K and is one of many events that take place around the nation to support the MRF. The MRF is a nonprofit and the largest independent organization devoted to melanoma.
About Aura Biosciences
Aura Biosciences is developing a new class of therapies to target and selectively destroy tumor cells. Its lead program in ocular melanoma, developed under a CRADA with the National Cancer Institute (NCI), has been granted orphan drug status by the U.S. Food and Drug Administration. For more information, visit www.aurabiosciences.com.
Ann Stanesa, 617-230-0347
Ten Bridge Communications